Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Reticulocyte hemoglobin content is the best indicator of iron deficiency causing hair loss in women.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.